Clinical Trials Logo

Clinical Trial Summary

Space clinical study aims to evaluate the performance, in terms of efficacy and safety of an intervertebral spacer associated with a bioceramic bone substitute in the context of intervertebral surgery for degenerative diseases. Specifically, it is intended to evaluate: - the capacity for bone regeneration/fusion, defined as absence of loosening and presence of continuous trabecular bone bridge in the absence of radiolucency lines, verified by imaging (CT) and evaluated according to the Brantingan scale; - the safety of the medical device, through the incidence of any adverse events, complications, unexpected reactions, accidents; - the improvement of clinical outcome in terms of pain and disability, at 9/14 months follow-up compared with preoperative scores, by clinical indices such as ODI and VAS.


Clinical Trial Description

n/a


Study Design


NCT number NCT05828784
Study type Interventional
Source SPS srl
Contact
Status Not yet recruiting
Phase N/A
Start date December 1, 2023
Completion date May 4, 2026